Observational studyBreast cancer research and treatment2025

Real-world quality-of-life of patients with HR+/HER2- advanced breast cancer treated with palbociclib plus endocrine therapy: EORTC QLQ-C30 results from POLARIS.

Gabrielle B Rocque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.